Introduction Semaglutide has revolutionized the treatment of type 2 diabetes and obesity, offering a unique combination of benefits for weight management, blood sugar control, and cardiovascular protection. As a GLP-1 receptor agonist, it mimics the natural hormone glucagon-like peptide-1, which regulates critical processes such as appetite, insulin secretion, and glucose https://limawebdirectory.com/listings536184/semaglutide-a-breakthrough-in-managing-diabetes-obesity-and-cardiovascular-health